| Dr Megan Brook Johnson, DPM | |
|
13019 W Linebaugh Ave Ste 101, Tampa, FL 33626 | |
| (813) 925-9431 | |
| Not Available |
| Full Name | Dr Megan Brook Johnson |
|---|---|
| Gender | Female |
| Speciality | Podiatry |
| Experience | 13 Years |
| Location | 13019 W Linebaugh Ave Ste 101, Tampa, Florida |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114211299 | NPI | - | NPPES |
| 480011623 | Other | FL | RAILROAD MEDICARE |
| 7720870001 | Other | FL | DMERC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | PO 3663 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Morton Plant Mease Healthcare Countryside | Safety harbor, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tidewater Foot And Ankle Associates, Inc. | 1850646779 | 2 |
News Archive
Molecular Detection Inc. (MDI), a company developing Detect-Ready™ assays designed to increase the speed and accuracy of infectious disease diagnosis, and Palex Medical S.A., one of Spain's leading distributors of medical device and diagnostic products to hospitals, today announced that they have entered into an exclusive distribution agreement for MDI's Detect-Ready™ MRSA assay in Spain.
A study out of Wake Forest University Baptist Medical Center demonstrates emergency room doctors are correctly identifying patients who are having a heart attack, even when laboratory tests haven't yet confirmed it.
Celgene Cellular Therapeutics, a wholly owned subsidiary of Celgene Corporation, today announced initial results from a Phase I multicenter safety study of PDA-001 in treatment-resistant Crohn's Disease. PDA-001 is an immunomodulatory therapy consisting of human placenta-derived cells obtained from CCT's proprietary processes.
Patients with bipolar disorder may be eligible for a new clinical research study comparing two medications - quetiapine, a widely prescribed second-generation antipsychotic mood-stabilizing medication, and lithium, the gold-standard mood stabilizer.
Tablet use has rocketed. Last year in the US, for example, 42% of under 18's owned one and more than half of 35-49 year olds used them regularly.
› Verified 6 days ago
| Provider Name | Bruce J Levine Dpm Pa |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1700995537 PECOS PAC ID: 8224066923 Enrollment ID: O20050803000632 |
News Archive
Molecular Detection Inc. (MDI), a company developing Detect-Ready™ assays designed to increase the speed and accuracy of infectious disease diagnosis, and Palex Medical S.A., one of Spain's leading distributors of medical device and diagnostic products to hospitals, today announced that they have entered into an exclusive distribution agreement for MDI's Detect-Ready™ MRSA assay in Spain.
A study out of Wake Forest University Baptist Medical Center demonstrates emergency room doctors are correctly identifying patients who are having a heart attack, even when laboratory tests haven't yet confirmed it.
Celgene Cellular Therapeutics, a wholly owned subsidiary of Celgene Corporation, today announced initial results from a Phase I multicenter safety study of PDA-001 in treatment-resistant Crohn's Disease. PDA-001 is an immunomodulatory therapy consisting of human placenta-derived cells obtained from CCT's proprietary processes.
Patients with bipolar disorder may be eligible for a new clinical research study comparing two medications - quetiapine, a widely prescribed second-generation antipsychotic mood-stabilizing medication, and lithium, the gold-standard mood stabilizer.
Tablet use has rocketed. Last year in the US, for example, 42% of under 18's owned one and more than half of 35-49 year olds used them regularly.
› Verified 6 days ago
| Provider Name | Tidewater Foot & Ankle Associates, Inc. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1629573217 PECOS PAC ID: 1850646779 Enrollment ID: O20180618002799 |
News Archive
Molecular Detection Inc. (MDI), a company developing Detect-Ready™ assays designed to increase the speed and accuracy of infectious disease diagnosis, and Palex Medical S.A., one of Spain's leading distributors of medical device and diagnostic products to hospitals, today announced that they have entered into an exclusive distribution agreement for MDI's Detect-Ready™ MRSA assay in Spain.
A study out of Wake Forest University Baptist Medical Center demonstrates emergency room doctors are correctly identifying patients who are having a heart attack, even when laboratory tests haven't yet confirmed it.
Celgene Cellular Therapeutics, a wholly owned subsidiary of Celgene Corporation, today announced initial results from a Phase I multicenter safety study of PDA-001 in treatment-resistant Crohn's Disease. PDA-001 is an immunomodulatory therapy consisting of human placenta-derived cells obtained from CCT's proprietary processes.
Patients with bipolar disorder may be eligible for a new clinical research study comparing two medications - quetiapine, a widely prescribed second-generation antipsychotic mood-stabilizing medication, and lithium, the gold-standard mood stabilizer.
Tablet use has rocketed. Last year in the US, for example, 42% of under 18's owned one and more than half of 35-49 year olds used them regularly.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Megan Brook Johnson, DPM 13019 W Linebaugh Ave Ste 101, Tampa, FL 33626-4507 Ph: (813) 925-9431 | Dr Megan Brook Johnson, DPM 13019 W Linebaugh Ave Ste 101, Tampa, FL 33626 Ph: (813) 925-9431 |
News Archive
Molecular Detection Inc. (MDI), a company developing Detect-Ready™ assays designed to increase the speed and accuracy of infectious disease diagnosis, and Palex Medical S.A., one of Spain's leading distributors of medical device and diagnostic products to hospitals, today announced that they have entered into an exclusive distribution agreement for MDI's Detect-Ready™ MRSA assay in Spain.
A study out of Wake Forest University Baptist Medical Center demonstrates emergency room doctors are correctly identifying patients who are having a heart attack, even when laboratory tests haven't yet confirmed it.
Celgene Cellular Therapeutics, a wholly owned subsidiary of Celgene Corporation, today announced initial results from a Phase I multicenter safety study of PDA-001 in treatment-resistant Crohn's Disease. PDA-001 is an immunomodulatory therapy consisting of human placenta-derived cells obtained from CCT's proprietary processes.
Patients with bipolar disorder may be eligible for a new clinical research study comparing two medications - quetiapine, a widely prescribed second-generation antipsychotic mood-stabilizing medication, and lithium, the gold-standard mood stabilizer.
Tablet use has rocketed. Last year in the US, for example, 42% of under 18's owned one and more than half of 35-49 year olds used them regularly.
› Verified 6 days ago
Dr. Paul Arthur Richter, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 7926 W Hillsborough Ave, Suite G, Tampa, FL 33615 Phone: 813-886-9180 Fax: 813-888-9093 | |
Juan J Rivera, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 2835 W De Leon St, Suite 101, Tampa, FL 33609 Phone: 813-254-6592 Fax: 813-254-3634 | |
Senior Foot Care Llc Podiatrist Medicare: Medicare Enrolled Practice Location: 12903 N Howard Ave, Tampa, FL 33612 Phone: 239-297-2876 | |
Paul L Sheehy Jr Dpm Pa Podiatrist Medicare: Medicare Enrolled Practice Location: 812 W Mlk Jr Blvd, Suite 101, Tampa, FL 33603 Phone: 813-872-8939 Fax: 813-872-8649 | |
Advanced Tampa Bay Foot Care Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 4543 S Manhattan Ave, Suite 104, Tampa, FL 33611 Phone: 813-831-3813 | |
Paul L Sheehy Jr, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 812 W Mlk Jr Blvd, Suite #101, Tampa, FL 33603 Phone: 813-872-8939 Fax: 813-872-8649 | |
Dr. Saleena Ruth Niehaus, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 508 S Habana Ave Ste 230, Tampa, FL 33609 Phone: 813-877-6636 |